NFT Limited financials

MI CIK 0001958713

Source: EDGAR filings · Built 2026-06-19T02:46:40Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
EBITDA -13.48M
Working Capital 99.68M 80.90M 60.80M 52.35M
Net Debt -62.11M
Gross Margin 73.54% 74.07% 74.15% 77.00%
Operating Margin -148.09% -122.35% -40.71% -275.73%
Net Margin -187.70% 850.08% 241.63% -304.20%
Return on Equity (ROE) -1.37% 7.78% 8.56% -19.76% -1083.07%
Return on Assets (ROA) -1.29% 7.27% 7.06% -15.28%
Current Ratio 17.13× 15.13× 5.72× 4.41×
Debt-to-Equity 0.03×
Effective Tax Rate -1.16% -5.63% -5.90% -2.73%
Cash Conversion Ratio 72.89× -0.21× -0.06× -0.39× 0.54×
Accruals Ratio 0.93× 0.09× 0.07× -0.21×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Revenue from Contract with Customer, Excluding Assessed Tax 2.15M 3.40M
Revenues 725.78K 740.70K 2.15M 3.40M
Cost of Revenue 192.05K 192.05K 556.59K 782.79K
Gross Profit 533.73K 548.65K 1.60M 2.62M
Operating Expenses 2.47M 12.01M 13.48M
Operating Income (Loss) -1.07M -906.27K -876.67K -9.38M -13.48M
Income Tax Expense (Benefit) 15.60K -335.75K 94.95K 255.81K
Net Income (Loss) Attributable to Parent -1.36M 6.30M 5.20M -10.35M -30.07M
Weighted Average Number of Shares Outstanding, Basic 8.67M 4.10M 654,419 495,877 247,675
Weighted Average Number of Shares Outstanding, Diluted 8.67M 4.10M 1.24M 495,877 247,675

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Cash and Cash Equivalents, at Carrying Value 2.81M 82.27M 61.75M 63.66M
Assets, Current 105.86M 86.62M 73.69M 67.69M
Assets 105.86M 86.62M 73.69M 67.75M
Liabilities, Current 6.18M 5.72M 12.89M 15.34M
Liabilities 6.18M 5.72M 12.89M 15.34M
Stockholders' Equity Attributable to Parent 99.68M 80.90M 60.80M 52.41M 2.78M
Common Stock, Shares, Outstanding 5.07M 1.40M 699,838

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Net Cash Provided by (Used in) Operating Activities -99.30M -1.34M -316.95K 4.08M -16.11M
Net Cash Provided by (Used in) Investing Activities 327.04K 129.21K -507.48K
Net Cash Provided by (Used in) Financing Activities 19.88M 21.90M -1.55M 61.55M 5.18M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MI CIK 0001958713), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

FISV

FISERV, INC.

ORIC

ORIC PHARMACEUTICALS, INC.

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL